On March 4, 2024, Ekso Bionics Holdings (NASDAQ: EKSO) released its Q4 earnings report. Here are the key takeaways from the announcement:
– Earnings: Ekso Bionics fell short of estimated earnings by -100.0%, with an EPS of $-0.22 compared to the expected $-0.11.
– Revenue: The company saw a $1.30 million increase in revenue from the same period last year.
– Past Performance: In the previous quarter, Ekso Bionics surpassed EPS estimates by $0.07, resulting in a 6.0% rise in share price the following day.
For the latest information and updates on Ekso Bionics Holdings, you can visit their investor relations page.
EKSO Stock Shows Strong Performance with 5.53% Increase on March 4, 2024
On March 4, 2024, EKSO stock closed at $2.10, marking a 5.53% increase from the previous market close. This upward momentum is indicative of positive investor sentiment towards the company. EKSO is currently trading in the middle of its 52-week range and above its 200-day simple moving average, suggesting stability and strength in its long-term trend. Despite a slight drop of $0.04 in after-hours trading, it is important to note that after-hours trading can be more volatile and may not always accurately reflect the overall market sentiment. Overall, EKSO’s stock performance on March 4, 2024, demonstrates strong price momentum and positive investor interest. Investors should continue to monitor the stock’s performance and any developments that may impact its future growth potential.
Ekso Bionics Holdings, Inc. Financial Performance Review 2024: Revenue Up, Net Loss Down
On March 4, 2024, Ekso Bionics Holdings, Inc. (EKSO) saw its stock performance reflect the company’s financial results for the past year and quarter. According to data from CNN Money, Ekso reported a total revenue of $12.91 million for the past year, which represented a 14.81% increase from the previous year. However, the total revenue remained flat at $4.61 million for the last quarter.
In terms of net income, Ekso reported a net loss of $15.08 million for the past year, marking a 54.44% decrease from the previous year. On a positive note, the net loss decreased by 20.45% to $3.37 million for the last quarter.
Earnings per share (EPS) for Ekso also showed a mixed performance. The company reported an EPS of -$1.16 for the past year, reflecting a 32.25% decrease from the previous year. However, the EPS improved by 22.92% to -$0.24 for the last quarter.
Overall, Ekso’s financial results for the past year and quarter indicate a mixed performance. While the company managed to increase its total revenue compared to the previous year, the net income and EPS figures showed declines for the year but improvements for the last quarter.
Investors and analysts will be closely monitoring Ekso’s future financial performance and operational strategies to assess the company’s growth potential and stock performance in the coming months. It will be interesting to see how Ekso addresses the challenges it faced in the past year and capitalizes on any opportunities for growth in the future.
